NCT07751484 Intalight Reference Database Protocol for VG200D
| NCT ID | NCT07751484 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Intalight, Inc |
| Condition | The Focus of This Study is to Collect OCT Data on Normal Eyes |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2026-07-08 |
| Primary Completion | 2026-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2026-07-08 with a primary completion date of 2026-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to collect OCT scans on normal healthy eyes from an investigational OCT device the VG200D from Intalight, Inc, in order to establish a reference database. The reference database will be used to establish normal ranges for thickness measurement parameters provided by the VG200D OCT software including anterior segment and posterior segment measurements. The study will enroll normal eyes from three clinics in the US including a wide range of ages and races/ethnicities.
Eligibility Criteria
Inclusion Criteria: * 1\. Subject 22 years of age or older on the date of informed consent 2. Subject able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. Subjects presenting at the site with normal eyes. Cataracts, LASIK, PRK, and peripheral pathology that does not affect the posterior pole region, for example lattice and peripheral drusen, are allowed. 4\. BCVA 20/40 or better (each eye) 5. Subject is able to comply with the study procedures Exclusion Criteria: * 1\. Subject unable to tolerate ophthalmic imaging 2. Subject has an ocular pathology other than cataract or mild peripheral, age-related changes (e.g., peripheral drusen, lattice, etc.) 3. Glaucoma diagnosis in either eye. 4. Subject has a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study 5. Subject with ocular media not sufficiently clear to obtain acceptable OCT images
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07751484 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, studying The Focus of This Study is to Collect OCT Data on Normal Eyes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07751484 currently recruiting?
Yes, NCT07751484 is actively recruiting participants. Contact the research team at mike.sinai@gmail.com for enrollment information.
Where is the NCT07751484 trial being conducted?
This trial is being conducted at San Diego, United States, Chicago, United States, Bloomington, United States.
Who is sponsoring the NCT07751484 clinical trial?
NCT07751484 is sponsored by Intalight, Inc. The trial plans to enroll 350 participants.